Fredun Pharmaceuticals’ board has recommended a 2:1 bonus issue, granting two new equity shares for every one held. This decision aims to reward shareholders, reflecting management’s confidence in the company’s sustained earnings growth, scalability, and long-term value creation strategy.
Recent Posts
- US-Iran War Live News Updates: Iran’s Foreign Ministry Condemns US Attack On Mine Laying Vessel As Ceasefire Violation
- Drishyam 3 Box Office Collection Day 5: Mohanlal Starrer Sees Weekday Drop — Collects This Amount
- IRDAI Tightens Rules On Executive Pay; Links Incentives To Claims, Customer Metrics
- Fino Payments Bank’s Interim CEO Ketan Merchant Gets Three-Month Extension From RBI
- Delhi high court asks SpiceJet to disclose assets in 2 weeks in $8 million Sunbird dues case